quantisnow
FeedTopReportsPricing
⌘K
Live feed
02:00:00·1459d
PRRelease
Capstar Special Purpose Acquisition Corp. logo
Social Capital Suvretta Holdings Corp. I logo
PureTech Health plc logo

PureTech Announces Annual Results for Year Ended December 31, 2021

CPSR· Capstar Special Purpose Acquisition Corp.DNAA· Social Capital Suvretta Holdings Corp. IPRTC· PureTech Health plc
FinanceHealth Care
Original source

Companies

  • CPSR
    Capstar Special Purpose Acquisition Corp.
    Finance
  • DNAA
    Social Capital Suvretta Holdings Corp. I
  • PRTC
    PureTech Health plc
    Health Care

Recent analyst ratings

  • Sep 9PRTCUpdateLeerink Partners$45.00
  • Jan 7PRTCUpdateSVB Leerink$70.00
  • Aug 25PRTCUpdateSVB Leerink$76.00

Related

  • PR11d
    PureTech Health: Notice of Results
  • PR21d
    PureTech Announces Publication of Phase 2b ELEVATE IPF Trial Results in The American Journal of Respiratory and Critical Care Medicine
  • PR21d
    PureTech Founded Entity Seaport Therapeutics Announces Positive Proof of Concept Topline Results from Ongoing Phase 1 Trial of GlyphAgo™ in Healthy Volunteers
  • PR29d
    PureTech Founded Entity Seaport Therapeutics Announces Publication in Science Translational Medicine Featuring GlyphAllo™ (SPT-300) as the First Triglyceride-Mimetic Prodrug to Achieve Therapeutically Relevant Drug Levels in Humans
  • PR58d
    PureTech to Present at the Leerink Partners Global Healthcare Conference
  • PR63d
    PureTech Announces Orphan Drug Designations Granted by the U.S. Food and Drug Administration and European Commission for Deupirfenidone (LYT-100) in Idiopathic Pulmonary Fibrosis
  • PR107d
    PureTech to Present at 44th Annual J.P. Morgan Healthcare Conference
  • SEC126d
    SEC Form 6-K filed by PureTech Health plc
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022